维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="SUTER TM"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial 显示文摘	Suter TM Procter M van Veldhuisen D J	2007	J Clin Oncol2007，25，25：	1
2	Cancer drugs and the heart: importance and management显示文摘	SUTER TM EWER MS	2013	Eur HeartJ2013，34，15：	1
3	显示文摘	Tschop M Statnick MA Suter TM	2002	Endocrinology2002，143，2：	1
4	Trastuzumab- associated cardiac adverse effects in the herceptin adjuvant trial 显示文摘	Suter TM Procter M van Veldhuisen DJ	2007	J Clin Oneol2007，25，25：	1
5	Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer 显示文摘	Suter TM Cook-Burns N Barton C	2004	Breast2004，13，3：	1
6	Chronic alpha-adrener- gic receptor stimulation modulates the contractile pheno- type of cardiac myocytes in vitro显示文摘	Satoh N Suter TM Liao R	2000	Circulation2000，102，18：	1
7	Cardiotoxicity associated with trastuzumab (Hereeptin) therapy in the treatment of metastatic breast eancer显示文摘	Suter TM Cook B Barton C	2004	Breast2004，13，3：	1
8	Feasibility and cardiac safety of trastuzumab emtansine after anthracycline-based chemotherapy as (neo) adjuvant therapy for human epidermal growth factor receptor 2-positive early-stage breast cancer显示文摘	Krop IE Suter TM Dang CT	2015	J Clin Onco12015，33，10：	1
9	Cardiotoxicity associated with Herceptin in the therapy of metastatic breast cancer 显示文摘	Barton C Suter TM Cook B	2003	Breast2003，12，4：	1
10	Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer 显示文摘	Suter TM Cook-Bruns N Barton C	2004	Breast2004，13，3：	1
11	Cancer drugs and the heart: importance andmanagement显示文摘	Suter TM Ewer MS	2013	Eur Heart J2013，34，15：	1
12	Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial 显示文摘	Suter TM Procter M van Veldhuisen DJ	2007	J Clin Oncol2007，25，25：	1
13	Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer显示文摘	Suter TM Cook B Barton C	2004	Breast2004，13，3：	1
14	Cancer drugs and the heart~ impor- tance and management显示文摘	Suter TM Ewer MS	2013	Eur Heart J2013，34，15：	1
15	Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant(HERA)trial显示文摘	Procter M Suter TM de Azambuja E		0，，：	1
16	Trastuzumab-associated cardiac adverse effects in the Herceptin adjuvant trial 显示文摘	Suter TM Procter M van Veldhuisen DJ	2007	J Clin Oncol2007，25，25：	1
17	Pathophysiology and diagnosis of cancer drug induced cardiomyopathy 显示文摘	Zuppinger C Timolati F Suter TM	2007	Cardiovasc Toxicol2007，7，2：	1
18	Pathophysiology and diagnosis of cancer drug induced cardiomyopathy 显示文摘	Zuppinger C Timolati F Suter TM	2007	Cardiovasc Toxicol2007，7，2：	1
19	Pathophysiology and diagno- sis of cancer drug induced cardiomyopathy显示文摘	Zuppinger C Timolati F Suter TM	2007	Cardiovasc Toxicol2007，7，2：	1
20	GH-releasing peptide-2 increases fat mass in mice acking NPY:indication for a crucial mediating role of hypothalamic agouti-related protein显示文摘	Statnick MA Suter TM	2002	Endocrinology2002，143，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示